http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
| My Groups | biotech-news Main Page | |
Pharma & Biotech Partnering Conference Attendee List Published in Final Announcement Before March 27-29 Gala Event in La Jolla, CA
LA JOLLA, Calif., Business development executives, CEOs, and investors from around the world will gather in two weeks to attend the "11th Annual Pharma & Biotech Licensing Deal-Making Summit." The organizer, Strategic Research Institute, is pleased to publish the evolving list of attending companies, which appears below. Hundreds of high-level executives are slated to attend, including delegates from:
3M
Abgenix
Actinium Pharmaceuticals, Inc
Allos Therapeutics
Altana Pharma US
Altea Therapeutics
Global Licensing, Amgen
Amylin Pharmaceuticals
Anadys Pharmaceuticals, Inc.
Arizona State University
Arizona Technology Enterprises
ARYx Therapeutics
AstraZeneca Pharmaceuticals LP
Bausch & Lomb
Baxter AG
Bayer HealthCare LLC - Animal Health Div.
Bioavailability Systems
Biogen Idec Inc.
Biolexis
BioScience Ventures
Bristol-Myers Squibb
Brown Rudnick LLP
Campbell Alliance
Capital Royalty L.P.
Catalyst Pharmaceutical Research, LLC
Celgene Corporation
Chelsea Therapeutics
CHL Medical
Cleveland Clinic
Daiichi Medical Research
Daiichi Pharmaceutical Corporation
Darier
Discovery Partners International
Eli Lilly and Company
Endo Pharmaceuticals
Ernest Gallo Clinic and Research Center
Fenwick & West, LLP
Flamel Technologies
Fortress Investment Group
FSC Laboratories
Genzyme Corporation
Gilead Sciences
H.I.G. Capital
Henry M. Jackson Foundation
Idenix Pharmaceuticals
Indevus Pharmaceuticals
InterMune
ISU ABXIS Co.
J.P. Morgan Partners
Johnson & Johnson
Keck Graduate Institute
Ligand Pharmaceuticals
Lilly Ventures
Louisiana State University
Medical College of Wisconsin Research Foundation
MedImmune, Inc.
VMerck & Co.
Merck Research Laboratories
MTB Investment Advisors
Novartis Pharma AG
Ovation Pharmaceuticals
Paddock Laboratories
Pennside Partners
Pfizer Inc
Pharmacyclics
PLx Pharma
Praecis Pharmaceuticals
Quintiles Transnational Corporation
RCP Diagnostics LLC
Roche Molecular Systems
sanofi-aventis Group
Schering-Plough Corporation
SCOLR Pharma, Inc.
SGX Pharmaceuticals
Somaxon Pharmaceuticals Inc.
SR One, A Wholly Owned Subsidiary of GlaxoSmithKline
Stanford University School of Medicine
TAP Pharmaceutical Products Inc.
The Dow Chemical Company
McNerney & Partners
University of New Mexico
Vital Therapies
Vrije Universiteit Brussels
Watson Pharmaceutical Inc.
Wyeth Pharmaceuticals
ZS Associates
Speakers include business development executives and investors from Genzyme, Merck, Indevus, sanofi-aventis, Bayer, Novartis, Roche, Pfizer, Schering Plough, Celgene, Abgenix, MedImmune, BiogenIDEC, Amylin, Ligand, Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, TAP, Wyeth, AstraZeneca, and GlaxoSmithKline, among others.
To request the agenda and/or the preliminary list of attendees, contact the organizer, Mark Alexay of Strategic Research Institute, at malexay @ srinstitute.com or at 212.967.0095, extension 251. Executive level Pharma, biotech, diagnostics, technology, medical device, and investor personnel are welcome to attend.
Source: Strategic Research Institute
YAHOO! GROUPS LINKS
- Visit your group "biotech-news" on the web.
- To unsubscribe from this group, send an email to:
[EMAIL PROTECTED]
- Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.
